guidelines:
  1: AIH_Revised_Original_Score_guideline.v1
test_cases:
- id: AIH score, no liver changes
  input:
    1:
      gt0004|Sex: 2|local::at0006|Female|
      gt0005|ALP:AST or ALP:ALT ratio: 0|local::at0009|1.5-3.0|
      gt0006|Serum globulins or IgG: 2|local::at0014|1.5-2.0|
      gt0007|ANA, SMA, or LKM-1 antibody: 3|local::at0020|>1:80|
      gt0008|AMA: 0|local::at0022|Negative|
      gt0009|Hepatitis viral markers: 3|local::at0022|Negative|
      gt0010|Recent or current use of hepatotoxic drugs: -4|local::at0029|Yes|
      gt0011|Average alcohol intake: 0|local::at0032|25-60 g/day|
      gt0012|Liver histology interface hepatitis: 0|local::at0028|No|
      gt0013|Liver histology predominantly lymphoplasmacytic infiltrate: 0|local::at0028|No|
      gt0014|Liver histology rosetting of liver cells: 0|local::at0028|No|
      gt0015|Liver histology biliary changes: 0|local::at0028|No|
      gt0016|Liver histology other changes: 0|local::at0028|No|
      gt0017|Other autoimmune disease(s): 0|local::at0028|No|
      gt0018|Response to therapy: 2|local::at0053|Complete|
  expected_output:
    1:
      gt0019|AIH score: 3,1
      gt0032|Diagnosis: local::at0012|Possible AIH. Other testing recommended.|
- id: AIH score antibody negative and additional parameters
  input:
    1:
      gt0004|Sex: 2|local::at0006|Female|
      gt0005|ALP:AST or ALP:ALT ratio: 0|local::at0009|1.5-3.0|
      gt0006|Serum globulins or IgG: 2|local::at0014|1.5-2.0|
      gt0007|ANA, SMA, or LKM-1 antibody: 0|local::at0017|<1:40|
      gt0008|AMA: 0|local::at0022|Negative|
      gt0009|Hepatitis viral markers: 3|local::at0022|Negative|
      gt0010|Recent or current use of hepatotoxic drugs: -4|local::at0029|Yes|
      gt0011|Average alcohol intake: 0|local::at0032|25-60 g/day|
      gt0012|Liver histology interface hepatitis: 0|local::at0028|No|
      gt0013|Liver histology predominantly lymphoplasmacytic infiltrate: 0|local::at0028|No|
      gt0014|Liver histology rosetting of liver cells: 0|local::at0028|No|
      gt0015|Liver histology biliary changes: 0|local::at0028|No|
      gt0016|Liver histology other changes: 0|local::at0028|No|
      gt0017|Other autoimmune disease(s): 0|local::at0028|No|
      gt0018|Response to therapy: 2|local::at0053|Complete|
      gt0033|Optional additional parameters: 2|local::at0059|Seropositivity for other defined autoantibodies|
  expected_output:
    1:
      gt0019|AIH score: 2,1
      gt0032|Diagnosis: local::at0012|Possible AIH. Other testing recommended.|
- id: AIH score with liver changes and negative antibody and additional parameters
  input:
    1:
      gt0004|Sex: 2|local::at0006|Female|
      gt0005|ALP:AST or ALP:ALT ratio: 0|local::at0009|1.5-3.0|
      gt0006|Serum globulins or IgG: 2|local::at0014|1.5-2.0|
      gt0007|ANA, SMA, or LKM-1 antibody: 0|local::at0017|<1:40|
      gt0008|AMA: 0|local::at0022|Negative|
      gt0009|Hepatitis viral markers: 3|local::at0022|Negative|
      gt0010|Recent or current use of hepatotoxic drugs: -4|local::at0029|Yes|
      gt0011|Average alcohol intake: 0|local::at0032|25-60 g/day|
      gt0012|Liver histology interface hepatitis: 3|local::at0029|Yes|
      gt0013|Liver histology predominantly lymphoplasmacytic infiltrate: 0|local::at0028|No|
      gt0014|Liver histology rosetting of liver cells: 0|local::at0028|No|
      gt0015|Liver histology biliary changes: 0|local::at0028|No|
      gt0016|Liver histology other changes: 0|local::at0028|No|
      gt0017|Other autoimmune disease(s): 0|local::at0028|No|
      gt0018|Response to therapy: 2|local::at0053|Complete|
      gt0033|Optional additional parameters: 2|local::at0059|Seropositivity for other defined autoantibodies|
  expected_output:
    1:
      gt0019|AIH score: 10,1
      gt0025|Diagnosis Pre-treatment: local::at0007|Probable AIH|
      gt0026|Diagnosis Post-treatment: local::at0014|possible AIH, other testing recommended.|
- id: Definite AIH
  input:
    1:
      gt0004|Sex: 2|local::at0006|Female|
      gt0005|ALP:AST or ALP:ALT ratio: 2|local::at0008|<1.5|
      gt0006|Serum globulins or IgG: 3|local::at0015|>2.0|
      gt0007|ANA, SMA, or LKM-1 antibody: 3|local::at0020|>1:80|
      gt0008|AMA: 0|local::at0022|Negative|
      gt0009|Hepatitis viral markers: 3|local::at0022|Negative|
      gt0010|Recent or current use of hepatotoxic drugs: 1|local::at0028|No|
      gt0011|Average alcohol intake: 2|local::at0031|<25 g/day|
      gt0012|Liver histology interface hepatitis: 3|local::at0029|Yes|
      gt0013|Liver histology predominantly lymphoplasmacytic infiltrate: 1|local::at0029|Yes|
      gt0014|Liver histology rosetting of liver cells: 1|local::at0029|Yes|
      gt0015|Liver histology biliary changes: 0|local::at0028|No|
      gt0016|Liver histology other changes: 0|local::at0028|No|
      gt0017|Other autoimmune disease(s): 2|local::at0029|Yes|
      gt0018|Response to therapy: 3|local::at0054|Relapse|
  expected_output:
    1:
      gt0019|AIH score: 26,1
      gt0025|Diagnosis Pre-treatment: local::at0006|Definite AIH|
      gt0026|Diagnosis Post-treatment: local::at0009|Definite AIH|
- id: Post-treatment Probable AIH
  input:
    1:
      gt0004|Sex: 0|local::at0005|Male |
      gt0005|ALP:AST or ALP:ALT ratio: -2|local::at0010|>3.0|
      gt0006|Serum globulins or IgG: 0|local::at0012|<1.0|
      gt0007|ANA, SMA, or LKM-1 antibody: 3|local::at0020|>1:80|
      gt0008|AMA: 0|local::at0022|Negative|
      gt0009|Hepatitis viral markers: 3|local::at0022|Negative|
      gt0010|Recent or current use of hepatotoxic drugs: 1|local::at0028|No|
      gt0011|Average alcohol intake: 2|local::at0031|<25 g/day|
      gt0012|Liver histology interface hepatitis: 3|local::at0029|Yes|
      gt0013|Liver histology predominantly lymphoplasmacytic infiltrate: 1|local::at0029|Yes|
      gt0014|Liver histology rosetting of liver cells: 1|local::at0029|Yes|
      gt0015|Liver histology biliary changes: 0|local::at0028|No|
      gt0016|Liver histology other changes: 0|local::at0028|No|
      gt0017|Other autoimmune disease(s): 2|local::at0029|Yes|
      gt0018|Response to therapy: 3|local::at0054|Relapse|
  expected_output:
    1:
      gt0019|AIH score: 17,1
      gt0025|Diagnosis Pre-treatment: local::at0006|Definite AIH|
      gt0026|Diagnosis Post-treatment: local::at0010|Probable AIH|
- id: score -19
  input:
    1:
      gt0004|Sex: 0|local::at0005|Male |
      gt0005|ALP:AST or ALP:ALT ratio: -2|local::at0010|>3.0|
      gt0006|Serum globulins or IgG: 0|local::at0012|<1.0|
      gt0007|ANA, SMA, or LKM-1 antibody: 0|local::at0017|<1:40|
      gt0008|AMA: -4|local::at0023|Positive|
      gt0009|Hepatitis viral markers: -3|local::at0023|Positive|
      gt0010|Recent or current use of hepatotoxic drugs: -4|local::at0029|Yes|
      gt0011|Average alcohol intake: -2|local::at0033|>60 g/day|
      'gt0012|Liver histology: interface hepatitis': 0|local::at0028|No|
      'gt0013|Liver histology: predominantly lymphoplasmacytic infiltrate': 0|local::at0028|No|
      'gt0014|Liver histology: rosetting of liver cells': 0|local::at0028|No|
      'gt0015|Liver histology: biliary changes': -3|local::at0029|Yes|
      'gt0016|Liver histology: other changes': -3|local::at0029|Yes|
      gt0017|Other autoimmune disease(s): 0|local::at0028|No|
      gt0018|Response to therapy: 2|local::at0053|Complete|
  expected_output:
    1:
      gt0019|AIH score: -24,1
      gt0032|Diagnosis: local::at0012|Possible AIH. Other testing recommended.|
- id: score 18
  input:
    1:
      gt0004|Sex: 2|local::at0006|Female|
      gt0005|ALP:AST or ALP:ALT ratio: 0|local::at0009|1.5-3.0|
      gt0006|Serum globulins or IgG: 1|local::at0013|1.0-1.5|
      gt0007|ANA, SMA, or LKM-1 antibody: 1|local::at0018|1:40|
      gt0008|AMA: 0|local::at0022|Negative|
      gt0009|Hepatitis viral markers: 3|local::at0022|Negative|
      gt0010|Recent or current use of hepatotoxic drugs: 1|local::at0028|No|
      gt0011|Average alcohol intake: 0|local::at0032|25-60 g/day|
      'gt0012|Liver histology: interface hepatitis': 3|local::at0029|Yes|
      'gt0013|Liver histology: predominantly lymphoplasmacytic infiltrate': 1|local::at0029|Yes|
      'gt0014|Liver histology: rosetting of liver cells': 1|local::at0029|Yes|
      'gt0015|Liver histology: biliary changes': 0|local::at0028|No|
      'gt0016|Liver histology: other changes': 0|local::at0028|No|
      gt0017|Other autoimmune disease(s): 2|local::at0029|Yes|
      gt0018|Response to therapy: 3|local::at0054|Relapse|
      gt0033|Optional additional parameters: 1|local::at0058|HLA-DR3 or HLA-DR4|
  expected_output:
    1:
      gt0019|AIH score: 18,1
      gt0025|Diagnosis Pre-treatment: local::at0006|Definite AIH|
      gt0026|Diagnosis Post-treatment: local::at0009|Definite AIH|
- id: score 24
  input:
    1:
      gt0004|Sex: 2|local::at0006|Female|
      gt0005|ALP:AST or ALP:ALT ratio: 2|local::at0008|<1.5|
      gt0006|Serum globulins or IgG: 2|local::at0014|1.5-2.0|
      gt0007|ANA, SMA, or LKM-1 antibody: 2|local::at0019|1:80|
      gt0008|AMA: 0|local::at0022|Negative|
      gt0009|Hepatitis viral markers: 3|local::at0022|Negative|
      gt0010|Recent or current use of hepatotoxic drugs: 1|local::at0028|No|
      gt0011|Average alcohol intake: 2|local::at0031|<25 g/day|
      'gt0012|Liver histology: interface hepatitis': 3|local::at0029|Yes|
      'gt0013|Liver histology: predominantly lymphoplasmacytic infiltrate': 1|local::at0029|Yes|
      'gt0014|Liver histology: rosetting of liver cells': 1|local::at0029|Yes|
      'gt0015|Liver histology: biliary changes': 0|local::at0028|No|
      'gt0016|Liver histology: other changes': 0|local::at0028|No|
      gt0017|Other autoimmune disease(s): 2|local::at0029|Yes|
      gt0018|Response to therapy: 3|local::at0054|Relapse|
      gt0033|Optional additional parameters: 2|local::at0059|Seropositivity for other defined autoantibodies|
  expected_output:
    1:
      gt0019|AIH score: 24,1
      gt0025|Diagnosis Pre-treatment: local::at0006|Definite AIH|
      gt0026|Diagnosis Post-treatment: local::at0009|Definite AIH|
- id: score 26
  input:
    1:
      gt0004|Sex: 2|local::at0006|Female|
      gt0005|ALP:AST or ALP:ALT ratio: 2|local::at0008|<1.5|
      gt0006|Serum globulins or IgG: 3|local::at0015|>2.0|
      gt0007|ANA, SMA, or LKM-1 antibody: 3|local::at0020|>1:80|
      gt0008|AMA: 0|local::at0022|Negative|
      gt0009|Hepatitis viral markers: 3|local::at0022|Negative|
      gt0010|Recent or current use of hepatotoxic drugs: 1|local::at0028|No|
      gt0011|Average alcohol intake: 2|local::at0031|<25 g/day|
      'gt0012|Liver histology: interface hepatitis': 3|local::at0029|Yes|
      'gt0013|Liver histology: predominantly lymphoplasmacytic infiltrate': 1|local::at0029|Yes|
      'gt0014|Liver histology: rosetting of liver cells': 1|local::at0029|Yes|
      'gt0015|Liver histology: biliary changes': 0|local::at0028|No|
      'gt0016|Liver histology: other changes': 0|local::at0028|No|
      gt0017|Other autoimmune disease(s): 2|local::at0029|Yes|
      gt0018|Response to therapy: 3|local::at0054|Relapse|
      gt0033|Optional additional parameters: 0|local::at0057|None of the above|
  expected_output:
    1:
      gt0019|AIH score: 26,1
      gt0025|Diagnosis Pre-treatment: local::at0006|Definite AIH|
      gt0026|Diagnosis Post-treatment: local::at0009|Definite AIH|
